Foci Pharmaceutical announced that Board Secretary Wang Junhui has resigned for personal reasons and will no longer hold any position in the company. The company convened a board meeting on July 28, 2026, and decided to appoint An Wenting as the new Board Secretary, with a term lasting until the end of the eighth board's tenure. An Wenting holds the Board Secretary qualification certificate from the Shenzhen Stock Exchange and possesses relevant professional capabilities and industry experience. In the first quarter of 2026, Foci Pharmaceutical achieved revenue of 212 million yuan and a net profit attributable to the parent company of 22.66 million yuan.
Lanzhou Foci Pharmaceutical Co LtdBoard secretary resignation and appointment are routine corporate governance changes with no clear impact on operations or financials.